首页 > 最新文献

The Australian and New Zealand journal of psychiatry最新文献

英文 中文
Abstract Appendix. 抽象的附录。
Pub Date : 1900-01-01 DOI: 10.1177/0004867418769823
{"title":"Abstract Appendix.","authors":"","doi":"10.1177/0004867418769823","DOIUrl":"https://doi.org/10.1177/0004867418769823","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"112 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124788439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Galvanizing mental health research in low and middle-income countries: role of scientific journals. 激励低收入和中等收入国家的精神卫生研究:科学期刊的作用。
Pub Date : 1900-01-01 DOI: 10.1185/135525704x15011
Giacomo Mauro DAriano
{"title":"Galvanizing mental health research in low and middle-income countries: role of scientific journals.","authors":"Giacomo Mauro DAriano","doi":"10.1185/135525704x15011","DOIUrl":"https://doi.org/10.1185/135525704x15011","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"104 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123411318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 26
The Psychiatry Ashes Test March update. 精神病学灰烬测试三月更新。
Pub Date : 1900-01-01 DOI: 10.1177/0004867418760201
{"title":"The Psychiatry Ashes Test March update.","authors":"","doi":"10.1177/0004867418760201","DOIUrl":"https://doi.org/10.1177/0004867418760201","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129891795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment-resistant depression. 难治性抑郁症。
Pub Date : 1900-01-01 DOI: 10.1007/978-3-642-36172-2_200431
P. Dignam
{"title":"Treatment-resistant depression.","authors":"P. Dignam","doi":"10.1007/978-3-642-36172-2_200431","DOIUrl":"https://doi.org/10.1007/978-3-642-36172-2_200431","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"58 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124088442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Victimization of patients with schizophrenia and related disorders. 精神分裂症及相关疾病患者受害。
Pub Date : 1900-01-01 DOI: 10.1111/j.1440-1614.2005.01539.x
P. Fitzgerald, A. D. de Castella, K. Filia, S. Filia, J. Benitez, J. Kulkarni
BACKGROUNDPrevious research has predominately focused on patients with mental illness as the instigators, rather than the victims, of violence and criminal activity. However, patients with schizophrenia appear to experience a higher degree of victimization compared to general community samples. We aimed to establish the 1-month prevalence of violent and non-violent victimization in a sample of patients with schizophrenia spectrum disorders and to investigate the determinants of victimization.METHODReports of violent and non-violent victimization were recorded in 348 patients in Dandenong, an outer metropolitan suburb of Melbourne, Australia along with the subjective perception of patients as to their degree of protection from being robbed or attacked. Patients reporting victimization were compared with those who did not, across a range of clinical and psychosocial variables.RESULTS11.2% of the sample reported being the victim of non-violent crime and 4.3% the victim of violent crime in the 1-month period. 23.2% reported dissatisfaction with their protection against being attacked or robbed. The major determinant of victimization was the lack of any meaningful daily activity.CONCLUSIONSPatients with schizophrenia spectrum disorders are at increased risk of victimization, both of the violent and non-violent type. Further research is required to understand the pathways through which victimization occurs and to understand whether psychosocial interventions can reduce victimization in this patient population.
以前的研究主要集中在精神疾病患者作为暴力和犯罪活动的煽动者,而不是受害者。然而,与一般社区样本相比,精神分裂症患者似乎经历了更高程度的受害。我们的目的是在精神分裂症谱系障碍患者样本中建立1个月暴力和非暴力伤害的流行情况,并调查伤害的决定因素。方法对澳大利亚墨尔本远郊丹德农348例患者的暴力和非暴力受害报告,以及患者对自己免受抢劫或袭击程度的主观感知进行记录。通过一系列临床和社会心理变量,将报告受害的患者与未报告受害的患者进行比较。结果在1个月内,11.2%的样本报告为非暴力犯罪的受害者,4.3%的样本报告为暴力犯罪的受害者。23.2%的受访者表示不满意他们免受袭击或抢劫的保护。受害的主要决定因素是缺乏任何有意义的日常活动。结论精神分裂症谱系障碍患者遭受暴力和非暴力伤害的风险均增加。需要进一步的研究来了解受害发生的途径,并了解社会心理干预是否可以减少这一患者群体的受害。
{"title":"Victimization of patients with schizophrenia and related disorders.","authors":"P. Fitzgerald, A. D. de Castella, K. Filia, S. Filia, J. Benitez, J. Kulkarni","doi":"10.1111/j.1440-1614.2005.01539.x","DOIUrl":"https://doi.org/10.1111/j.1440-1614.2005.01539.x","url":null,"abstract":"BACKGROUND\u0000Previous research has predominately focused on patients with mental illness as the instigators, rather than the victims, of violence and criminal activity. However, patients with schizophrenia appear to experience a higher degree of victimization compared to general community samples. We aimed to establish the 1-month prevalence of violent and non-violent victimization in a sample of patients with schizophrenia spectrum disorders and to investigate the determinants of victimization.\u0000\u0000\u0000METHOD\u0000Reports of violent and non-violent victimization were recorded in 348 patients in Dandenong, an outer metropolitan suburb of Melbourne, Australia along with the subjective perception of patients as to their degree of protection from being robbed or attacked. Patients reporting victimization were compared with those who did not, across a range of clinical and psychosocial variables.\u0000\u0000\u0000RESULTS\u000011.2% of the sample reported being the victim of non-violent crime and 4.3% the victim of violent crime in the 1-month period. 23.2% reported dissatisfaction with their protection against being attacked or robbed. The major determinant of victimization was the lack of any meaningful daily activity.\u0000\u0000\u0000CONCLUSIONS\u0000Patients with schizophrenia spectrum disorders are at increased risk of victimization, both of the violent and non-violent type. Further research is required to understand the pathways through which victimization occurs and to understand whether psychosocial interventions can reduce victimization in this patient population.","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"118535996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
Single dose pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients. 锂在台湾/中国双相患者中的单剂量药代动力学研究。
Pub Date : 1900-01-01 DOI: 10.1046/j.1440-1614.1998.00366.x
C. Lee, Y. Y. Yang, O. Hu
OBJECTIVEThe purpose of this study is to investigate the single dose pharmacokinetics of lithium in Taiwanese/Chinese bipolar patients for future interracial comparisons.METHODEight bipolar patients took 900 mg of lithium carbonate after overnight fasting. Blood samples of 5 mL were taken after 15 min, 30 min, 45 min, 1 h, 2 h, 3 h, 4 h, 7 h, 9 h, 15 h, 25 h and 31 h after dosing. The computer programs CSTRIP and PCNONLIN were used for pharmacokinetic analysis.RESULTSThe pharmacokinetic parameters obtained were as follows: Cmax, 0.970 +/- 0.170 (SD) mmol/L; Tmax, 1.59 +/- 0.78 h; AUC31 h = 548.9 +/- 135.4 mmol x m/L; AUC to infinity = 722.6 +/- 262.7 mmol x m/L; beta-half-life = 16.3 +/- 7.18 h; kappa-half-life = 0.613 +/- 0.442 h; Cl(oral) = 1.13 +/- 0.39 mL/min/kg; Vd/F = 1.43 +/- 0.387 L/kg. Most of the pharmacokinetic parameters were within the ranges reported in investigations of Caucasian subjects.CONCLUSIONSThis study showed that racial differences in lithium pharmacokinetics might not exist. We suggest that methodological designs, including method of blood sampling, measurement of lithium, and pharmacokinetic and statistical calculations, be standardised if future cross-ethnic comparisons are to be conducted.
目的研究锂在台湾/中国双相情感障碍患者中的单剂量药代动力学,以便将来进行种族间比较。方法8例双相患者禁食一夜后服用900毫克碳酸锂。给药后15 min、30 min、45 min、1 h、2 h、3 h、4 h、7 h、9 h、15 h、25 h、31 h取5 mL血样。采用计算机程序CSTRIP和PCNONLIN进行药代动力学分析。结果获得的药动学参数为:Cmax 0.970 +/- 0.170 (SD) mmol/L;Tmax, 1.59 +/- 0.78 h;AUC31 h = 548.9 +/- 135.4 mmol × m/L;AUC至无穷远= 722.6 +/- 262.7 mmol x m/L;-半衰期= 16.3 +/- 7.18 h;kappa半衰期= 0.613 +/- 0.442 h;Cl(口服)= 1.13 +/- 0.39 mL/min/kg;Vd/F = 1.43±0.387 L/kg。大部分药代动力学参数在白种人调查报告的范围内。结论本研究表明,锂的药代动力学可能不存在种族差异。我们建议,如果将来要进行跨种族比较,方法学设计,包括血液采样方法、锂的测量、药代动力学和统计计算,应该标准化。
{"title":"Single dose pharmacokinetic study of lithium in Taiwanese/Chinese bipolar patients.","authors":"C. Lee, Y. Y. Yang, O. Hu","doi":"10.1046/j.1440-1614.1998.00366.x","DOIUrl":"https://doi.org/10.1046/j.1440-1614.1998.00366.x","url":null,"abstract":"OBJECTIVE\u0000The purpose of this study is to investigate the single dose pharmacokinetics of lithium in Taiwanese/Chinese bipolar patients for future interracial comparisons.\u0000\u0000\u0000METHOD\u0000Eight bipolar patients took 900 mg of lithium carbonate after overnight fasting. Blood samples of 5 mL were taken after 15 min, 30 min, 45 min, 1 h, 2 h, 3 h, 4 h, 7 h, 9 h, 15 h, 25 h and 31 h after dosing. The computer programs CSTRIP and PCNONLIN were used for pharmacokinetic analysis.\u0000\u0000\u0000RESULTS\u0000The pharmacokinetic parameters obtained were as follows: Cmax, 0.970 +/- 0.170 (SD) mmol/L; Tmax, 1.59 +/- 0.78 h; AUC31 h = 548.9 +/- 135.4 mmol x m/L; AUC to infinity = 722.6 +/- 262.7 mmol x m/L; beta-half-life = 16.3 +/- 7.18 h; kappa-half-life = 0.613 +/- 0.442 h; Cl(oral) = 1.13 +/- 0.39 mL/min/kg; Vd/F = 1.43 +/- 0.387 L/kg. Most of the pharmacokinetic parameters were within the ranges reported in investigations of Caucasian subjects.\u0000\u0000\u0000CONCLUSIONS\u0000This study showed that racial differences in lithium pharmacokinetics might not exist. We suggest that methodological designs, including method of blood sampling, measurement of lithium, and pharmacokinetic and statistical calculations, be standardised if future cross-ethnic comparisons are to be conducted.","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"119096252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Pathological gambling. 病态赌博。
Pub Date : 1900-01-01 DOI: 10.1036/1097-8542.yb081660
C. Allcock
According to DSM-III criteria, pathological gambling is now recognised as a mental illness. Epidemiological data suggest that the incidence of this disorder in the general population varies from 0.5% to 1%. However, until recently, psychiatrists and clinical psychologists have tended to neglect the problem because of a lack of understanding of its aetiology and management. This paper describes pathological gambling and presents an overview of current psychiatric treatments. It concludes that behavioural interventions are the most effective treatments for compulsive gamblers.
根据DSM-III的标准,病态赌博现在被认为是一种精神疾病。流行病学资料表明,这种疾病在一般人群中的发病率从0.5%到1%不等。然而,直到最近,由于缺乏对其病因和管理的了解,精神科医生和临床心理学家往往忽视了这个问题。本文描述了病态赌博,并提出了目前的精神治疗的概述。它的结论是,行为干预是治疗嗜赌成瘾者最有效的方法。
{"title":"Pathological gambling.","authors":"C. Allcock","doi":"10.1036/1097-8542.yb081660","DOIUrl":"https://doi.org/10.1036/1097-8542.yb081660","url":null,"abstract":"According to DSM-III criteria, pathological gambling is now recognised as a mental illness. Epidemiological data suggest that the incidence of this disorder in the general population varies from 0.5% to 1%. However, until recently, psychiatrists and clinical psychologists have tended to neglect the problem because of a lack of understanding of its aetiology and management. This paper describes pathological gambling and presents an overview of current psychiatric treatments. It concludes that behavioural interventions are the most effective treatments for compulsive gamblers.","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131635156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Schizophrenia today. 今天精神分裂症。
Pub Date : 1900-01-01 DOI: 10.1037/016052
B. Maher
{"title":"Schizophrenia today.","authors":"B. Maher","doi":"10.1037/016052","DOIUrl":"https://doi.org/10.1037/016052","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130489436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Personality disorders. 人格障碍。
Pub Date : 1900-01-01 DOI: 10.1176/appi.books.9781585624836.jb18
E. Berah, G. Mellsop
{"title":"Personality disorders.","authors":"E. Berah, G. Mellsop","doi":"10.1176/appi.books.9781585624836.jb18","DOIUrl":"https://doi.org/10.1176/appi.books.9781585624836.jb18","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115053027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Informed consent. 知情同意。
Pub Date : 1900-01-01 DOI: 10.1007/978-3-319-61738-1_5
D. Spencer
{"title":"Informed consent.","authors":"D. Spencer","doi":"10.1007/978-3-319-61738-1_5","DOIUrl":"https://doi.org/10.1007/978-3-319-61738-1_5","url":null,"abstract":"","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134307439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Australian and New Zealand journal of psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1